Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05354232 · ClinicalTrials.gov registry record · NA

Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)

A NA study of Attention Deficit Disorder With Hyperactivity and Attention Deficit Disorder, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05354232 is a NA study of Attention Deficit Disorder With Hyperactivity and Attention Deficit Disorder that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 60 participants, below the 352-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05354232, a NA study of Attention Deficit Disorder With Hyperactivity and Attention Deficit Disorder, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The investigators are investigating whether home-based tDCS over the course of four weeks can improve ADHD symptom severity and improve dysexecutive functioning (cognitive control). Further, the investigators are investigating whether there is a dose-dependent response to tDCS.

Conditions Studied

Attention Deficit Disorder With Hyperactivity Attention Deficit Disorder

Interventions

  • DEVICE 2 mA transcranial direct current stimulation (tDCS)
  • DEVICE 1 mA transcranial direct current stimulation (tDCS)
  • DEVICE Sham transcranial direct current stimulation (tDCS)

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Charlestown

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-07-01
Est. Completion 2026-05
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05354232

The ClinicalTrials.gov registry entry for NCT05354232 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 352-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target (83% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Attention Deficit Disorder With Hyperactivity appearing as the primary indexed condition, and to 3 interventions - of which 2 mA transcranial direct current stimulation (tDCS) is the first listed.

NCT05354232 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05354232 about?

NCT05354232 is a clinical study titled "Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)". The investigators are investigating whether home-based tDCS over the course of four weeks can improve ADHD symptom severity and improve dysexecutive functioning (cognitive control). Further, the investigators are investigating whether there is a dose-dependent response to tDCS.

What is the current status of trial NCT05354232?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-07-01. Estimated completion is 2026-05.

What conditions does trial NCT05354232 study?

This clinical trial studies the following conditions: Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder.

What interventions are being tested in trial NCT05354232?

The interventions under investigation include: 2 mA transcranial direct current stimulation (tDCS) (DEVICE), 1 mA transcranial direct current stimulation (tDCS) (DEVICE), Sham transcranial direct current stimulation (tDCS) (DEVICE).

Who is sponsoring clinical trial NCT05354232?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05354232 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Attention Deficit Disorder With Hyperactivity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Attention Deficit Disorder With Hyperactivity

All registered trials for this condition

Attention Deficit Disorder

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.